Literature DB >> 7233461

Giant fusiform aneurysm of the cerebral arteries.

J R Little, P St Louis, M Weinstein, D F Dohn.   

Abstract

Giant fusiform aneurysm of the cerebral arteries was found in 11 patients during a 20-year period. The 7 males and 4 females ranged in age from 9 to 68 years (mean: 49 years). The supraclinoid segment of the internal carotid artery (ICA) and the M-1 segment of the middle cerebral artery (MCA) were the most frequently involved arteries. Multiple aneurysms were identified in 3 patients. Compression of adjacent intracranial structures was the usual cause of symptoms, and only 2 patients experienced subarachnoid hemorrhage. One patient presented with transient ischemic attacks. Computed tomography, with and without Hypaque infusion, clearly demonstrated the aneurysms in the 6 of 7 patients studied. Thrombus was invariably seen in the lumen of the aneurysm. Cerebral angiography in 11 patients displayed marked dilatation and elongation of the involved artery. The dilatation frequently extended into connecting arteries. Surgical treatment was carried out in 6 patients, including 2 with aneurysm entrapment and decompression, 2 with proximal ICA ligation, 1 with wrapping and 1 with wrapping and superficial temporal artery (STA) to MCA anastomosis. Death occurred in 2 patients not treated surgically.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7233461     DOI: 10.1161/01.str.12.2.183

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Long-term follow-up of ruptured intracranial aneurysms treated by microsurgical wrapping with autologous muscle.

Authors:  Antonino Germanò; Stefano Priola; Filippo Flavio Angileri; Alfredo Conti; Domenico La Torre; Salvatore Cardali; Giovanni Raffa; Lucia Merlo; Francesca Granata; Marcello Longo; Francesco Tomasello
Journal:  Neurosurg Rev       Date:  2012-07-10       Impact factor: 3.042

2.  Giant and large peripheral cerebral aneurysms: etiopathologic considerations, endovascular treatment, and long-term follow-up.

Authors:  A Biondi; B Jean; E Vivas; L Le Jean; A L Boch; J Chiras; R Van Effenterre
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

3.  Incidental intracranial vascular pathology in patients investigated for carotid stenosis.

Authors:  P D Griffiths; S Worthy; A Gholkar
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

Review 4.  Dolichoectasia of the internal carotid artery terminus, posterior communicating artery, and posterior cerebral artery: The embryonic caudal ramus internal carotid segmental vulnerability legacy.

Authors:  Chai Kobkitsuksakul; Kittiphop Somboonnitiphol; Mungkorn Apirakkan; Peerapong Lueangapapong; Ekachat Chanthanaphak
Journal:  Interv Neuroradiol       Date:  2019-08-22       Impact factor: 1.610

5.  Fusiform aneurysm of the proximal anterior cerebral artery.

Authors:  M Shigemori; T Kawaba; Y Yoshitake; J Miyagi; S Kuramoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

Review 6.  Giant cerebral aneurysms.

Authors:  H W Pia; J Zierski
Journal:  Neurosurg Rev       Date:  1982       Impact factor: 3.042

7.  Progressive CT changes in cerebral arterial dolichoectasia.

Authors:  P Van Tassel; T el Gammal
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

8.  Giant fusiform aneurysm of the vertebro-basilar artery presenting with stroke.

Authors:  F Ildan; E Cetinalp; H Bagdatoglu; B Boyar; Z Uzuneyüpoglu; A Karadayi
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

9.  Reconstruction of the middle cerebral artery after excision of a giant fusiform aneurysm.

Authors:  S Ceylan; A Karakuş; S Duru; S Baykal; K Ilbay
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 10.  Giant fusiform aneurysm in middle cerebral artery branches: a report of two cases and a review of the literature.

Authors:  M Borzone; M Altomonte; M Baldini; C Silvestro; C Rivano
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.